![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » TAP INITIATES STUDIES FOR GASTROENTEROLOGY PRODUCT
TAP INITIATES STUDIES FOR GASTROENTEROLOGY PRODUCT
TAP Pharmaceutical is initiating Phase III studies for an investigational new product, TAK-390MR, for the treatment of acid-related disorders. In addition to the development of TAK-390MR, TAP will be focusing development efforts on other investigational products for gastroenterological conditions.
Phase I clinical trial data have shown that TAK-390MR may have the potential to bring additional benefits to patients who suffer from acid-related diseases, the firm said.
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
21Oct